<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05623969</url>
  </required_header>
  <id_info>
    <org_study_id>atrial cardiopathay</org_study_id>
    <nct_id>NCT05623969</nct_id>
  </id_info>
  <brief_title>Markers of Atrial Cardiopathay</brief_title>
  <official_title>Markers of Atrial Cardiopathay</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Marker of atrial cardiopathay as apredictor value of ischemic stroke&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      detection of the presence of atrial dysfunction or atrial cardiopathy and its degree among&#xD;
      patients complaining of palpitation, with a one-year follow-up for any cardioembolic events&#xD;
      (stroke /TIA).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2022</start_date>
  <completion_date type="Anticipated">November 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of any underlying arrythmia after holter monitoring for twenty four hours</measure>
    <time_frame>Detection of any underlying arrythmia after holter monitoring for twenty four hours</time_frame>
    <description>Detection of any underlying arrythmia after holter monitoring for twenty four hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with 6 month follow-up for any cardioembolic events (stroke /TIA).</measure>
    <time_frame>Detection of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with 6 month follow-up for any cardioembolic events (stroke /TIA).</time_frame>
    <description>Detection of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with 6 month follow-up for any cardioembolic events (stroke /TIA).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Atrial Cardiopathy</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Holter ,Echo , Speckle tracking echocardiography</intervention_name>
    <description>A 24-h ambulatory Holter Echocardiography Speckle tracking echocardiography (STE)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        - Patients complaining of palpitation referred for Holter monitoring&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients complaining of palpitation referred for Holter monitoring&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ Valvular AF, moderate to severe mitral/ tricuspid/ aortic stenosis or regurgitation.&#xD;
&#xD;
               -  Recent myocardial infarction within 3 months.&#xD;
&#xD;
               -  Acute pulmonary embolism.&#xD;
&#xD;
               -  Newly onset AF during or shortly after cardiac surgery.&#xD;
&#xD;
               -  Specific type of cardiomyopathy such as cardiac amyloidosis, obstructive&#xD;
                  hypertrophic cardiomyopathy.&#xD;
&#xD;
        Decompensation stage of organ failure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammed Aboelkassem Farghal, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mariam zarief farhan, resident</last_name>
    <phone>01009427245</phone>
    <email>mariamzarif134@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amr Ahmed Aly Youssef, professor</last_name>
    <phone>01027355511</phone>
    <email>amryoussef111@aun_edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mariam zarief farhan</name>
      <address>
        <city>Assiut</city>
        <zip>23123</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 2, 2022</study_first_submitted>
  <study_first_submitted_qc>November 13, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2022</study_first_posted>
  <last_update_submitted>November 28, 2022</last_update_submitted>
  <last_update_submitted_qc>November 28, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mariam Zarief Farhan</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

